Laboratory study investigates whether Symprove can inhibit Clostridioides difficile

A laboratory study has demonstrated that Symprove inhibited the growth of Clostridioides difficile (formerly Clostridium difficile), a common cause of antibiotic-associated diarrhoea and healthcare...

Symprove outperforms 7 leading probiotics in independent study

An independent in vitro study has explored the mechanism of action and survivability of 8 commercially available probiotic products in the UK, finding that liquid-based formulations outperform caps...

Randomised controlled trial shows potential of probiotics for IBS symptom severity

A randomised clinical trial has reported a statistically significant improvement in overall symptoms in adults with irritable bowel syndrome (IBS) following 12 weeks of supplementation with a liqui...